Natalizumab: immune effects and implications for therapy.
Hauser
Stephen L
SL
Weiner
Howard L
HL
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D039441:Integrin alpha4 / Q000502:physiology; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D000069442:Natalizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000069442:Natalizumab; D039441:Integrin alpha4